These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9207856)

  • 21. Structural aspects of Vitamin D endocrinology.
    Rochel N; Molnár F
    Mol Cell Endocrinol; 2017 Sep; 453():22-35. PubMed ID: 28257826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L7 protein is a coregulator of vitamin D receptor-retinoid X receptor-mediated transactivation.
    Berghöfer-Hochheimer Y; Zurek C; Wölfl S; Hemmerich P; Munder T
    J Cell Biochem; 1998 Apr; 69(1):1-12. PubMed ID: 9513041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast.
    Kephart DD; Walfish PG; DeLuca H; Butt TR
    Mol Endocrinol; 1996 Apr; 10(4):408-19. PubMed ID: 8721985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A perspective on how the Vitamin D sterol/Vitamin D receptor (VDR) conformational ensemble model can potentially be used to understand the structure-function results of A-ring modified Vitamin D sterols.
    Mizwicki MT; Bula CM; Bishop JE; Norman AW
    J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):69-82. PubMed ID: 16055325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity.
    Anami Y; Sakamaki Y; Itoh T; Inaba Y; Nakabayashi M; Ikura T; Ito N; Yamamoto K
    Bioorg Med Chem; 2015 Nov; 23(22):7274-81. PubMed ID: 26515040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance of HBL100 human breast epithelial cells to vitamin D action.
    Agadir A; Lazzaro G; Zheng Y; Zhang XK; Mehta R
    Carcinogenesis; 1999 Apr; 20(4):577-82. PubMed ID: 10223184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand recognition by the vitamin D receptor.
    Choi M; Yamamoto K; Masuno H; Nakashima K; Taga T; Yamada S
    Bioorg Med Chem; 2001 Jul; 9(7):1721-30. PubMed ID: 11425573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional activation of the wild-type and mutant vitamin D receptors by vitamin D3 analogs.
    Futawaka K; Tagami T; Fukuda Y; Koyama R; Nushida A; Nezu S; Yamamoto H; Imamoto M; Kasahara M; Moriyama K
    J Mol Endocrinol; 2016 Jul; 57(1):23-32. PubMed ID: 27154546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of the vitamin D receptor by vitamin D lactam derivatives.
    Asano L; Waku T; Abe R; Kuwabara N; Ito I; Yanagisawa J; Nagasawa K; Shimizu T
    FEBS Lett; 2016 Sep; 590(18):3270-9. PubMed ID: 27500498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells.
    Meyer MB; Watanuki M; Kim S; Shevde NK; Pike JW
    Mol Endocrinol; 2006 Jun; 20(6):1447-61. PubMed ID: 16574738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The function of vitamin D receptor in vitamin D action.
    Kato S
    J Biochem; 2000 May; 127(5):717-22. PubMed ID: 10788778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1,25-Dihydroxyvitamin D3 up-regulates the renal vitamin D receptor through indirect gene activation and receptor stabilization.
    Healy KD; Frahm MA; DeLuca HF
    Arch Biochem Biophys; 2005 Jan; 433(2):466-73. PubMed ID: 15581603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D receptor ligands: the impact of crystal structures.
    Carlberg C; Molnár F; Mouriño A
    Expert Opin Ther Pat; 2012 Apr; 22(4):417-35. PubMed ID: 22449247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.
    Herdick M; Steinmeyer A; Carlberg C
    Chem Biol; 2000 Nov; 7(11):885-94. PubMed ID: 11094341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanism of vitamin D receptor action.
    Issa LL; Leong GM; Eisman JA
    Inflamm Res; 1998 Dec; 47(12):451-75. PubMed ID: 9892040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D analogue-specific recruitment of vitamin D receptor coactivators.
    Issa LL; Leong GM; Sutherland RL; Eisman JA
    J Bone Miner Res; 2002 May; 17(5):879-90. PubMed ID: 12009019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Characterization of ligand-dependent transactivation regions of the human vitamin D receptor].
    Nakajima S
    Nihon Rinsho; 1998 Jul; 56(7):1717-21. PubMed ID: 9702043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VDR-Alien: a novel, DNA-selective vitamin D(3) receptor-corepressor partnership.
    Polly P; Herdick M; Moehren U; Baniahmad A; Heinzel T; Carlberg C
    FASEB J; 2000 Jul; 14(10):1455-63. PubMed ID: 10877839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts.
    Thompson PD; Remus LS; Hsieh JC; Jurutka PW; Whitfield GK; Galligan MA; Encinas Dominguez C; Haussler CA; Haussler MR
    J Mol Endocrinol; 2001 Oct; 27(2):211-27. PubMed ID: 11564604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation.
    Alimirah F; Peng X; Yuan L; Mehta RR; von Knethen A; Choubey D; Mehta RG
    Exp Cell Res; 2012 Nov; 318(19):2490-7. PubMed ID: 22884583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.